Inhibrx Employee Directory

Inhibrx corporate office is located in 11025 N Torrey Pines Rd Ste 140, La Jolla, California, 92037, United States and has 51-200 employees.

Likely to Engage tag.Highly Engaged Employees

Employees by Department

Departments

Number of employees

Engineering & Technical

15

Medical & Health

7

Operations

6

Finance

4

Human Resources

1

Legal

1

Sales

1

Key Employees of Inhibrx

  • David Matly, President at Inhibrx
    United States flag for contact location.
    David Matly

    President

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Inhibrx Global Presence

globalPresence illustration
North America51-200
Europe1-10

Index of contact profiles from Inhibrx

Hundreds of professionals searching for Inhibrx have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
123

Former Employees at Inhibrx

Explore people who held key positions, contributed to Inhibrx's success, and advanced their careers.

People from Similar Companies in the Business Services Industry Located in California, United States

Frequently Asked Questions Regarding Inhibrx Employees

How many employees does Inhibrx have?
Inhibrx has 51-200 employees
Who are Inhibrx key employees?
Some of Inhibrx key employees are David Matly
Where is Inhibrx located?
Inhibrx’s headquarters are located at 11025 N Torrey Pines Rd Ste 140, La Jolla, California, 92037, United States
How do I contact Inhibrx?
Inhibrx Contact Info: Phone number: (858) 795-4220 Website: www.inhibrx.com
What does Inhibrx do?

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 that is in phase 2 clinical trial for the treatment of unresectable or m... etastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 that is in phase 2 clinical trial for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck cancer, gastric and gastroesophageal adenocarcinoma cancer, renal cell carcinoma, and urothelial cell carcinoma. The company was incorporated in 2024 and is based in La Jolla, California.Read More

Is Inhibrx a public company?
Yes, Inhibrx is a public company and is traded under the symbol INBX
See more information about Inhibrx Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.